Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
Drug companies produce eye drops at a size much larger than the human eye can hold, reports ProPublica.
The Food and Drug Administration on Monday granted market clearance to Stryker's cementless knee implant.
Amneal Pharmaceuticals and Impax Laboratories will combine to form the fifth largest generics business in the country, based on revenue.
The United Kingdom and European Union have yet to reach a trade deal for medications ahead of Britain's 2019 exit from the EU, according to Bloomberg.
Michael Laufer, PhD, a college professor and leader in the growing biohacker movement, wants to teach patients how to make their own medications to subvert the drug industry's high prices, according to STAT.
Here are six drug and medical device companies that made headlines in the past week.
Roche formed a strategic collaboration with the drug discovery company Warp Drive Bio to develop new classes of antibiotics.
The Food and Drug Administration on Friday expanded the approval for Johnson & Johnson's psoriasis drug Stelara.
The FDA approved a new robotically- assisted surgical device, Senhance System, to facilitate minimally invasive surgeries.
Baxter International anticipates a temporary shortage of small saline IV bags in the U.S. due to manufacturing issues in hurricane-damaged Puerto Rico, reports USA Today.